AM251: A Practical CB1 Receptor Antagonist Workflow
2026-09-09
AM251 enables controlled disruption of CB1 signaling in receptor, synaptic, behavioral, metabolic, and cell-cycle assays. This workflow connects nanomolar pharmacology with practical controls, formulation guidance, and troubleshooting for cannabinoid receptor research.
Cisapride in iPSC-CM Cardiotoxicity Workflows
2026-09-08
Cisapride (R 51619) combines 5-HT4 receptor agonism with hERG channel inhibition, making it a useful mechanistic stressor for cardiac electrophysiology research. In iPSC-derived cardiomyocyte assays, it can connect high-content morphology, deep-learning phenotypes, and orthogonal electrophysiology for earlier cardiac arrhythmia risk assessment.
WQ-C-401 Blocks PDGFR-Driven Pulmonary Remodeling
2026-09-08
The reference study identifies WQ-C-401 as a selective PDGFR inhibitor that reduced pulmonary vascular remodeling, right ventricular pressure, and inflammatory-cell accumulation in a monocrotaline model of pulmonary arterial hypertension. Its combination of kinome profiling, cell-based signaling assays, and in vivo pathology provides a useful framework for evaluating PDGFR-directed therapies beyond established comparator drugs.
Phalloidin B7678: F-Actin Workflow Guide
2026-09-07
Phalloidin B7678 is a cyclic heptapeptide toxin used to bind and stabilize filamentous actin for fixed-sample cytoskeleton visualization. This guide covers preparation, assay setup, quality control, and troubleshooting, while defining why the reagent should not be used for live-cell imaging or experiments that require reversible actin remodeling.
Bestatin Hydrochloride: Mechanism & Research Use
2026-09-05
Bestatin hydrochloride, also called Ubenimex, is a research inhibitor of aminopeptidase N/CD13 and aminopeptidase B. Evidence supports its use for aminopeptidase activity, neuronal angiotensin processing, angiogenesis inhibition, and cancer research, while model-specific limits remain important.
Monkeypox Replication Inhibitors: Mubritinib Study Insights
2026-09-05
Chiem et al. developed a reporter-virus screening strategy that identified compounds capable of inhibiting vaccinia virus and, for a subset, monkeypox virus replication in vitro. Mubritinib was among the confirmed hits, making TAK 165 a candidate for follow-up antiviral pharmacology while underscoring that the study established phenotypic activity rather than a defined molecular mechanism or therapeutic efficacy.
DiscoveryProbe Protease Inhibitor Library Workflow
2026-09-04
Move from broad protease activity modulation to mechanism-focused validation with an automation-ready compound collection. This workflow shows how to connect biochemical screening, cell-based phenotyping, apoptosis assay design, and resistance studies while controlling DMSO, cytotoxicity, and assay-interference risks.
GPR107 Deficiency and Diabetic Nephropathy
2026-09-04
Xu et al. identify GPR107 as a podocyte endocytic regulator that restrains collagen type IV accumulation in diabetic nephropathy. Their findings connect impaired AT1R internalization with Ca2+-CREB signaling, increased collagen synthesis, reduced MMP-2 expression, and worsening glomerular basement membrane pathology.
Vernakalant Hydrochloride: Assay Design Guide
2026-09-03
This scenario-based guide explains how to use Vernakalant Hydrochloride (SKU A3915) in ion-channel and cell viability workflows without confusing electrophysiological activity with nonspecific cytotoxicity. It covers concentration selection, solvent controls, orthogonal readouts, data interpretation, and practical supplier comparison.
Naloxone Hydrochloride: A Mechanism-First Guide
2026-09-03
Explore how Naloxone hydrochloride functions as an opioid receptor antagonist across receptor-dependent and receptor-independent assays. This mechanism-first guide connects opioid signaling, neural stem cell proliferation modulation, immune studies, and rigorous experimental controls.
Sulfo-NHS-Biotin: Chemistry, Controls, and Assay Design
2026-09-02
Sulfo-NHS-Biotin is a water-soluble amine-reactive reagent for controlled protein and cell-surface labeling. This guide connects its reaction chemistry with assay design and explains when random chemical biotinylation should give way to site-specific AviTag/BirA strategies.
Suhuang, ER Stress, and NLRP3 in Cough Variant Asthma
2026-09-02
The reference study shows that Suhuang antitussive capsule protects against pulmonary dysfunction in an ovalbumin-induced cough variant asthma model by suppressing endoplasmic reticulum stress and downstream NLRP3 inflammasome activation. Its key mechanistic contribution is the proposed connection between calcium trafficking, PKCε, TXNIP, the RIP1–RIP3–Drp1 pathway, and inflammatory caspase-1 signaling.
WP1066: Mapping JAK2/STAT3 Across Cancer and Repair
2026-09-01
WP1066 is more than a pathway inhibitor: it is a cell-permeable pharmacological counterprobe for determining when JAK2/STAT3 signaling drives malignant persistence or supports reparative macrophage function. This article connects cancer biology, renal carcinoma and AML models with emerging biomaterial research while defining practical validation strategies and translational limitations.
Tunable Human Intestinal Organoids: Study Insights
2026-09-01
The reference study develops a human small-intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a single culture condition. Its small-molecule strategy also enables reversible or directional control of lineage output, offering a more scalable framework for intestinal development, disease modeling, and screening.
Diuron Workflows for Plant and Renal Toxicology
2026-08-31
Diuron supports two distinct research use cases: controlled photosynthesis-inhibition assays in plant systems and mechanistic toxicology studies in HK-2 renal cells. This workflow-focused guide connects solvent handling, dose-response design, JAK2/STAT1 validation, and troubleshooting for more reproducible results.
508 records 9/34 page Previous Next First page 上5页 678910 下5页 Last page